Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
What are the regulatory challenges faced by the 3D printing of pharmaceuticals, and how do we overcome them?
Overcoming Regulatory Challenges In 3D Printing of Pharmaceuticals
CSO Achim Schneeberger Discusses the Development of Laxxon's Levodopa Project
CEO Helmut Kerschbaumer discusses Laxxon's Partnership with Hovione
Digital Communication and Patient Experience
3-Dimensional Screen Printing of Pharmaceuticals
Evonik & Laxxon: An Innovative Force
Individualized and Customized Medicine’s Important Role in the Future of Healthcare
The History of Generic Drugs in the United States